Cellceutix Corporation - Product Pipeline Review - 2016

  • ID: 3846517
  • Company Profile
  • 157 pages
  • Global Markets Direct
  • Cellceutix
1 of 4
Cellceutix Corporation - Product Pipeline Review - 2016

Summary

‘Cellceutix Corporation - Product Pipeline Review - 2016’, provides an overview of the Cellceutix Corporation’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Cellceutix Corporation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Cellceutix Corporation
- The report provides overview of Cellceutix Corporation including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Cellceutix Corporation’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Cellceutix Corporation’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Cellceutix Corporation’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Cellceutix Corporation
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Cellceutix Corporation’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

Cellceutix Corporation Snapshot

Cellceutix Corporation Overview

Key Information

Key Facts

Cellceutix Corporation - Research and Development Overview

Key Therapeutic Areas

Cellceutix Corporation - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Cellceutix Corporation - Pipeline Products Glance

Cellceutix Corporation - Clinical Stage Pipeline Products

Cellceutix Corporation - Early Stage Pipeline Products

Cellceutix Corporation - Drug Profiles

brilacidin tetrahydrochloride

KM-133

KM-3174

CC-1807

CTIX-1278

CTIX-1502

KM-277

KM-278

KM-362

KM-391

KM-732

PMX-0196

PMX-0243

PMX-10072

PMX-10098

PMX-1207

PMX-1241

PMX-1278

PMX-1405

PMX-1408

PMX-20005

PMX-207

PMX-225

PMX-231

PMX-255

PMX-30016

PMX-30024

PMX-496

PMX-504

PMX-519

PMX-611

PMX-647

PMX-835

Small Molecule to Disrupt Cell Membrane for Hidradenitis Suppurativa

PMX-100

PMX-1014

PMX-1045

PMX-1056

PMX-1057

PMX-1090

PMX-1091

PMX-1094

PMX-1099

PMX-1102

PMX-1142

PMX-1363

PMX-1424

PMX-1442

PMX-1445

PMX-1467

PMX-1488

PMX-1533

PMX-1547

PMX-1555

PMX-1560

PMX-1570

PMX-1572

PMX-1573

PMX-1576

PMX-1591

PMX-1625

PMX-183

PMX-223

PMX-229

PMX-247

PMX-520

PMX-633

PMX-668

PMX-693

PMX-70004

PMX-728

PMX-741

PMX-843

PMX-868

Cellceutix Corporation - Pipeline Analysis

Cellceutix Corporation - Pipeline Products by Target

Cellceutix Corporation - Pipeline Products by Route of Administration

Cellceutix Corporation - Pipeline Products by Molecule Type

Cellceutix Corporation - Pipeline Products by Mechanism of Action

Cellceutix Corporation - Recent Pipeline Updates

Cellceutix Corporation - Dormant Projects

Cellceutix Corporation - Locations And Subsidiaries

Head Office

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

Cellceutix Corporation, Key Information

Cellceutix Corporation, Key Facts

Cellceutix Corporation - Pipeline by Indication, 2016

Cellceutix Corporation - Pipeline by Stage of Development, 2016

Cellceutix Corporation - Monotherapy Products in Pipeline, 2016

Cellceutix Corporation - Phase II, 2016

Cellceutix Corporation - Phase I, 2016

Cellceutix Corporation - Preclinical, 2016

Cellceutix Corporation - Discovery, 2016

Cellceutix Corporation - Pipeline by Target, 2016

Cellceutix Corporation - Pipeline by Route of Administration, 2016

Cellceutix Corporation - Pipeline by Molecule Type, 2016

Cellceutix Corporation - Pipeline Products by Mechanism of Action, 2016

Cellceutix Corporation - Recent Pipeline Updates, 2016

Cellceutix Corporation - Dormant Developmental Projects,2016 154List of Figures

Cellceutix Corporation - Pipeline by Top 10 Indication, 2016

Cellceutix Corporation - Pipeline by Stage of Development, 2016

Cellceutix Corporation - Monotherapy Products in Pipeline, 2016

Cellceutix Corporation - Pipeline by Target, 2016

Cellceutix Corporation - Pipeline by Route of Administration, 2016

Cellceutix Corporation - Pipeline by Molecule Type, 2016

Cellceutix Corporation - Pipeline Products by Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll